Physician profile
Susan E Joseph
NPI 1225424393
$649.61
in general payments reported to CMS, 2019-2025
14 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $342 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $130.07 | 2021-2022 | |
| Abbott Laboratories | $113.52 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lundbeck LLC | $105.22 | 2021-2022 | |
| Neos Therapeutics, LP | $57.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $56.99 | 2022 | |
| Eisai INC. | $34.43 | 2021 | |
| Merck Sharp & Dohme LLC | $31.77 | 2022 | |
| Orexo US, INC. | $20.22 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.99 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.46 | 2021 | |
| Alfasigma USA, INC. | $17.26 | 2022 | |
| Alkermes, INC. | $15.26 | 2022 | |
| Owp Pharmaceuticals, INC. | $14.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.